Travaux scientifiques

Prof. Dr. Fahriye Tuğba Köş

109 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil

  1. Real-world effectiveness of total neoadjuvant therapy in locally advanced rectal cancer: a multicenter retrospective study

    Discover Oncology, 2026

    DOI 10.1007/s12672-026-04842-3 PMID 41870760 Texte intégral en libre accèsSource : OpenAlex

  2. Combined halp and GRIm scores for risk stratification in metastatic pancreatic ductal adenocarcinoma

    Future oncology (London, England), 2026

    DOI 10.1080/14796694.2026.2732589 PMID 42730632 Source : Europe PMC

  3. Pembrolizumab associated immune thrombocytopenia

    Journal of chemotherapy (Florence, Italy), 2026

    DOI 10.1080/1120009x.2025.2468045 PMID 39972542 Source : Europe PMC

  4. Re: Three versus Six Cycles of Platinum-Based Chemotherapy Followed by Avelumab Maintenance as First-Line Treatment for Advanced Urothelial Cancer: The Phase II DISCUS Trial

    European Urology, 2026

    DOI 10.1016/j.eururo.2026.03.010 PMID 41925429 Source : OpenAlex

  5. Nailfold capillaroscopy findings after anthracycline-based chemotherapy and their association with subclinical changes in left ventricular ejection fraction

    BMC Cancer, 2026

    DOI 10.1186/s12885-026-16187-9 PMID 42151866 Texte intégral en libre accèsSource : OpenAlex

  6. Survival Outcomes in ERBB2- Low vs ERBB2- Null Advanced Gastric Cancer

    JAMA Network Open, 2026

    DOI 10.1001/jamanetworkopen.2026.24180 PMID 42479431 Texte intégral en libre accèsSource : OpenAlex

  7. Timing of Second-Line Nivolumab and Survival in Metastatic Renal Cell Carcinoma

    Clinical Genitourinary Cancer, 2026

    DOI 10.1016/j.clgc.2026.102653 PMID 42700745 Source : OpenAlex

  8. Clinical and microbiological characteristics of abscesses in patients with malignancy and factors associated with 90-day mortality

    Frontiers in Cellular and Infection Microbiology, 2026

    DOI 10.3389/fcimb.2026.1969735 Texte intégral en libre accèsSource : OpenAlex

  9. Preoperative 18F-fluorodeoxyglucose PET/computed tomography maximum standardized uptake value is independently associated with overall survival in surgically resected undifferentiated pleomorphic sarcoma

    Nuclear Medicine Communications, 2026

    DOI 10.1097/mnm.0000000000002255 PMID 42929044 Source : OpenAlex

  10. Survival–Toxicity Trade-Offs Between Trifluridine/Tipiracil and Regorafenib in Refractory Metastatic Colorectal Cancer: A Simulation-Based Reinforcement Learning Study

    Eurasian Journal of Medical Investigation, 2026

    DOI 10.14744/ejmi.2612601 Source : OpenAlex

  11. Anorectal Malignant Melanoma: Diagnostic Pitfalls and Prognostic Insights from a Single-Center Retrospective Analysis

    Diagnostics, 2025

    DOI 10.3390/diagnostics15162086 PMID 40870938 2 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  12. Prognostic Factors and Long-Term Survival in Kaposi’s Sarcoma Patients: Results from a 28-Year Retrospective Cohort

    Medicina, 2025

    DOI 10.3390/medicina61040724 PMID 40283016 1 citation (Europe PMC) Texte intégral en libre accèsSource : ORCID

  13. A New Prognostic Indicator for Biliary Tract Cancers: The ABIC Score

    Current Oncology, 2025

    DOI 10.3390/curroncol32040200 PMID 40277757 2 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  14. The HALP score as a prognostic factor in metastatic biliary cancer

    Clinical and Translational Oncology, 2025

    DOI 10.1007/s12094-024-03702-2 PMID 39271621 6 citations (Europe PMC) Source : ORCID

  15. Predicting hepatocellular carcinoma survival with artificial intelligence

    Scientific Reports, 2025

    DOI 10.1038/s41598-025-90884-6 PMID 39979406 30 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  16. Gram-negative bacterial bloodstream infections in cancer patients: a study of epidemiological trends and antibiotic susceptibility

    Tropical Medicine and Health, 2025

    DOI 10.1186/s41182-025-00811-8 PMID 41057968 7 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  17. Predicting survival outcomes in advanced pancreatic cancer using machine learning methods

    Medicine, 2025

    DOI 10.1097/md.0000000000043904 PMID 40826793 4 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  18. Association of RAD51 expression with response to neoadjuvant treatment and prognosis in locally advanced gastric cancer

    Expert Review of Anticancer Therapy, 2025

    DOI 10.1080/14737140.2025.2555468 PMID 40883868 1 citation (OpenAlex) Source : OpenAlex

  19. Adjuvant nivolumab vs pembrolizumab in stage IIB/IIC melanoma: a reinforcement learning-based simulation study

    Clinical & Translational Oncology, 2025

    DOI 10.1007/s12094-025-04090-x PMID 41182652 1 citation (OpenAlex) Source : OpenAlex

  20. The predictive value of sarcopenia and PET imaging metrics in metastatic non-squamous NSCLC

    Biomarkers in Medicine, 2025

    DOI 10.1080/17520363.2025.2540758 PMID 40753467 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  21. Comparison of clinical, pathological, and prognostic features of small bowel tumors

    Oncology in Clinical Practice, 2025

    DOI 10.5603/ocp.102621 Texte intégral en libre accèsSource : OpenAlex

  22. Clinicopathological features of patients with human epidermal growth factor receptor 2 (HER2) immunohistochemistry 2+ early-stage breast cancer

    The Annals of Clinical and Analytical Medicine, 2025

    DOI 10.4328/acam.22464 Texte intégral en libre accèsSource : OpenAlex

  23. HALP–GRIms Synergy Offers Superior Prognostic and Predictive Precision in Advanced Pancreatic Ductal Adenocarcinoma

    Research Square, 2025

    DOI 10.21203/rs.3.rs-7277845/v1 Texte intégral en libre accèsSource : OpenAlex

  24. Prognostic Value of the Hemoglobin Albumin Lymphocyte Platelet Score in Extrapulmonary Neuroendocrine Carcinomas

    Acta haematologica oncologica Turcica., 2025

    DOI 10.4274/ahot.galenos.2025.2025-7-1 Texte intégral en libre accèsSource : OpenAlex

  25. Bevacizumab versus aflibercept with FOLFIRI after FOLFOX and bevacizumab in RAS mutant metastatic colon cancer a Turkish oncology group study

    Scientific Reports, 2024

    DOI 10.1038/s41598-024-81371-5 PMID 39616250 2 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  26. Refractory hypoglycemia is sensitive to octreotide therapy: is it triggered by sorafenib or hepatocellular carcinoma?

    Anti-Cancer Drugs, 2024

    DOI 10.1097/cad.0000000000001669 PMID 39625742 2 citations (OpenAlex) Source : OpenAlex

  27. The Comparison of FLOT and DCF Regimens as Perioperative Treatment for Gastric Cancer

    Oncology, 2024

    DOI 10.1159/000540517 PMID 39079501 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  28. Clinical features and prognostic factors in thymoma and thymic carcinoma

    Indian Journal of Thoracic and Cardiovascular Surgery, 2024

    DOI 10.1007/s12055-024-01741-6 PMID 39416339 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  29. Comparison of Prognostic Values of Seven Immune Indexes in Advanced Non-Small-Cell Lung Cancer Treated with Nivolumab: How Effective Can They Be Regarding Our Treatment Decisions?

    Medicina, 2024

    DOI 10.3390/medicina60111792 PMID 39596977 14 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  30. Prognostic factors of adult granulosa cell tumors of the ovary: a Turkish retrospective multicenter study

    Journal of Gynecologic Oncology, 2024

    DOI 10.3802/jgo.2024.35.e39 PMID 38156722 4 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  31. Cabozantinib-induced heart failure

    Journal of Oncology Pharmacy Practice, 2024

    DOI 10.1177/10781552231203703 PMID 37817663 2 citations (Europe PMC) Source : ORCID

  32. Pembrolizumab related perforated appendicitis

    Journal of Oncology Pharmacy Practice, 2024

    DOI 10.1177/10781552241271026 PMID 39095043 1 citation (Europe PMC) Source : ORCID

  33. Prognostic significance of pretreatment clinical and laboratory features in patients with ovarian cancer receiving neoadjuvant chemotherapy

    Oncology in Clinical Practice, 2024

    DOI 10.5603/ocp.100576 1 citation (OpenAlex) Texte intégral en libre accèsSource : ORCID

  34. Comparison of Different Machine Learning Models for Predicting Long-Term Overall Survival in Non-metastatic Colorectal Cancers

    Cureus, 2024

    DOI 10.7759/cureus.75713 PMID 39811215 14 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  35. Comparison of the Clinical Features and Prognostic Value of Inflammation-Based Markers in Uterine Leiomyosarcoma

    Dicle Medical Journal / Dicle Tip Dergisi, 2024

    DOI 10.5798/dicletip.1552473 Texte intégral en libre accèsSource : OpenAlex

  36. A rare EGFR exon 19 insertion mutation in metastatic lung adenocarcinoma: a favorable response to afatinib

    Anti-Cancer Drugs, 2024

    DOI 10.1097/cad.0000000000001671 PMID 39749551 Source : OpenAlex

  37. COMPARISON OF METACOGNITION AND METAEMOTION IN BREAST CANCER PATIENTS WITH HEALTHY CONTROLS

    AYBU AVESIS, 2024

    Source : OpenAlex

  38. Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group

    The Oncologist, 2023

    DOI 10.1093/oncolo/oyad257 PMID 37676712 8 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  39. Management and prognosis of patients with cancer of unknown primary: 20 years of experience

    Turkish journal of medical sciences, 2023

    DOI 10.55730/1300-0144.5741 PMID 38813492 2 citations (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

  40. Simple and easily accessible prognostic markers in ewing sarcoma; neutrophil-lymphocyte ratio, neutrophil-platelet score and systemic-inflammation index

    Journal of Cancer Research and Therapeutics, 2023

    DOI 10.4103/jcrt.jcrt_1741_21 PMID 37787290 8 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  41. Toxic hepatitis in metastatic breast cancer patient using ribociclib and denosumab

    Journal of Oncology Pharmacy Practice, 2023

    DOI 10.1177/10781552231174593 PMID 37170613 1 citation (Europe PMC) Source : ORCID

  42. Clinicopathological and survival features of neuroendocrine tumors: A retrospective analysis of 153 cases, our current remarks on a heterogeneous tumor group, and still unmet future expectations.

    Journal of cancer research and therapeutics, 2023

    DOI 10.4103/jcrt.jcrt_353_22 PMID 37006071 3 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  43. Clinicopathologİcal Features and Survival Outcomes of 70 Tongue Squamous Cell Carcinoma Patients

    Acta Oncologica Turcica, 2022

    DOI 10.5505/aot.2022.59002 Texte intégral en libre accèsSource : OpenAlex

  44. Are tyrosine kinase inhibitors as effective as they are safe in renal cell cancer patients over the age of 65?

    Annals of Clinical and Analytical Medicine, 2022

    DOI 10.4328/acam.20833 Texte intégral en libre accèsSource : ORCID

  45. Does Prognostic Nutritional Index Predict Survival in Operated Papilla Vateri Tumors? A Single-centre Experience

    Journal of College of Physicians and Surgeons Pakistan, 2021

    DOI 10.29271/jcpsp.2021.12.1428 PMID 34794282 1 citation (Europe PMC) Texte intégral en libre accèsSource : ORCID

  46. Is there any correlation among MKK4(mitogen-activated protein kinase kinase 4)expression, clinicopathological features, and KRAS/NRAS mutation in colorectal cancer

    Expert Review of Molecular Diagnostics, 2020

    DOI 10.1080/14737159.2020.1784728 PMID 32552144 2 citations (Europe PMC) Source : ORCID

  47. Correlation betwen MKK4 expression (exp) and clinicopathological features, KRAS/NRAS mutation in metastatic colorectal cancer (mCRC)

    Journal of Clinical Oncology, 2019

    DOI 10.1200/jco.2019.37.15_suppl.e14500 Source : ORCID

  48. Prognostic factors in nonfunctional well-differentiated gastroenteropancreatic neuroendocrine tumors: Single Institute Experience

    Journal of Clinical Oncology, 2018

    DOI 10.1200/jco.2018.36.15_suppl.e16176 Source : ORCID

  49. Neutrophil–lymphocyte ratio, platelet–lymphocyte ratio, neutrophil–platelet score and prognostic nutritional index: do they have prognostic significance in metastatic pancreas cancer?

    Current Medical Research and Opinion, 2017

    DOI 10.1080/03007995.2017.1408579 PMID 29161926 30 citations (OpenAlex) Source : OpenAlex

  50. Metastatik prostat karsinomlu hastalarda sağkalım analizi ve prognostik faktörler; Tek merkez deneyimi

    AYBU AVESIS, 2017

    Source : OpenAlex